SUBSCRIBE
SUBSCRIBE

Bristol Myers Squibb Company

NEWS
Pharm Country
Big Pharma Blurring the Lines with Big Biotech; Novartis International AG (Jobs), Abbott Laboratories (Jobs), Wyeth (Jobs), Bristol-Myers Squibb Company (Jobs) Hedging Their Bets with Biotech drugs; Less Vulnerability to Generics
May 30, 2007
 · 
1 min read
Biotech Beach
The Day In Review: Entereg from GlaxoSmithKline and Adolor Corporation Fails Test
April 10, 2007
 · 
1 min read
The Day In Review: Will Sanofi-Aventis (France) Merge With Bristol-Myers Squibb Company?
January 30, 2007
 · 
1 min read
Biotech Beach
The Day In Review: Bristol-Myers Squibb Company In $1.2 Billion Pact With AstraZeneca PLC
January 11, 2007
 · 
1 min read
Bio NC
The Day In Review: Targacept, Inc. Climbs On AstraZeneca PLC Payment
December 27, 2006
 · 
1 min read
BioMidwest
The Day In Review: Eli Lilly and Company Stops Brain Cancer Trial
December 22, 2006
 · 
1 min read
Genetown
Second “Large Biotech” Interested In Devens, Massachusetts; More Jobs To Genetown
December 19, 2006
 · 
1 min read
Biotech Beach
The Day In Review: BioSante Pharmaceuticals, Inc. Rises On FDA Approval
December 18, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Deals Dominate Biotech News
December 12, 2006
 · 
1 min read
Load More
AWARDS
  • 2026 - Best Places to Work - Badge (1).png
  • 2024 Best Places to Work
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
December 22, 2025
 · 
10 min read
Press Releases
Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026
December 18, 2025
 · 
1 min read
Press Releases
Bristol Myers Squibb Canada Welcomes Positive CDA Recommendation for OPDIVO® Plus YERVOY® as First-Line Treatment for MSI-H/dMMR Metastatic Colorectal Cancer
December 17, 2025
 · 
5 min read
Press Releases
U.S. Food and Drug Administration (FDA) Grants Priority Review to Bristol Myers Squibb’s Application for Opdivo® (nivolumab) Plus Chemotherapy Combination for Classical Hodgkin Lymphoma
December 12, 2025
 · 
19 min read
Press Releases
Quebec becomes first province in Canada to list new subcutaneous OPDIVO® on public drug plan for solid tumour indications
December 12, 2025
 · 
4 min read
Press Releases
Bristol Myers Squibb Announces Dividend Increase - December 10, 2025
December 11, 2025
 · 
1 min read
Press Releases
BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer
December 10, 2025
 · 
15 min read
Press Releases
Bristol Myers Squibb Advances Lymphoma Research with New Targeted Protein Degradation and Cell Therapy Data at ASH 2025
December 9, 2025
 · 
19 min read
Press Releases
Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)
December 5, 2025
 · 
19 min read
Press Releases
Bristol Myers Squibb Announces Continuation of ADEPT-2 Phase 3 Study in Psychosis Associated with Alzheimer’s Disease
December 3, 2025
 · 
4 min read
Load More